These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32535095)

  • 21. HIV and SARS-CoV-2: points to consider to face this new pandemic.
    Prieto Pozo AA; Salvador Sagüez FLD
    Medwave; 2020 Oct; 20(9):e8049. PubMed ID: 33141814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 24. Do pets protect their owners in the COVID-19 era?
    Jurgiel J; Filipiak KJ; Szarpak Ł; Jaguszewski M; Smereka J; Dzieciątkowski T
    Med Hypotheses; 2020 Sep; 142():109831. PubMed ID: 32428810
    [No Abstract]   [Full Text] [Related]  

  • 25. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [COVID-19- what have we learned and where are we heading?].
    Gudnason T
    Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
    [No Abstract]   [Full Text] [Related]  

  • 27. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the molecular determinants of the SARS-CoV-2 attack.
    Kanduc D; Shoenfeld Y
    Clin Immunol; 2020 Jun; 215():108426. PubMed ID: 32311462
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC; Silverman RH
    Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host Immune Response Driving SARS-CoV-2 Evolution.
    Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
    Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathology of COVID-19: where are the neuropathologists?
    Glatzel M
    Brain Pathol; 2020 Jul; 30(4):729. PubMed ID: 32592310
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 34. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
    Papachristodoulou E; Kakoullis L; Parperis K; Panos G
    Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 38. Human papillomavirus: The other invisible enemy.
    Abel MK; Huh WK; Chan JK
    Gynecol Oncol; 2020 Aug; 158(2):254-255. PubMed ID: 32518014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.
    Rajkumar RP
    Med Hypotheses; 2020 Oct; 143():110116. PubMed ID: 32721808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
    Rodríguez Y; Novelli L; Rojas M; De Santis M; Acosta-Ampudia Y; Monsalve DM; Ramírez-Santana C; Costanzo A; Ridgway WM; Ansari AA; Gershwin ME; Selmi C; Anaya JM
    J Autoimmun; 2020 Nov; 114():102506. PubMed ID: 32563547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.